Knockdown of GPX4 or pharmacologic inhibition of this pathway re-sensitized EBV-infected NPC cells to ferroptosis, suggesting viral involvement in reinforcing Nrf2-mediated antioxidant defenses. This evidence concerns the gene NFE2L2 and nasopharyngeal carcinoma.